Related Experiment Video
Updated: Apr 27, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Radiation recall after a transarterial hepatic chemoembolization
Kevin A Wunderle1, Mark J Sands2
1Department of Radiology, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; Department of Medical Physics, Wayne State University, Detroit, Michigan..
Abstract:
Radiation recall is a rare side effect observed in patients treated with certain medications after radiation therapy. This effect mimics a radiation-induced tissue reaction in expression; however, it occurs outside of the traditional time course and only in the presence of a catalyzing agent. The authors report a case of radiation recall resulting from an interaction between radiation delivered during a fluoroscopically guided hepatic chemoembolization for treatment of metastatic carcinoid tumor and the oral chemotherapeutic agents capecitabine and temozolomide administered 7 weeks later.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013